Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes

The morphological components of cerebral white matter disease (WMD) were studied in 17 cases of clinically diagnosed dementia and neuropathologically verified Alzheimer's disease (AD) with concomitant WMD. The distribution of grey and white matter changes was evaluated and overall as well as regional severity was graded. Total glial numbers in frontal white matter were counted using a light microscope. Oligodendrocyte and astrocyte quantities as well as astrocytic reactivity were assessed from frontal and parietal lobe white matter using a computer assisted morphometric method. The AD–WMD group was compared with 10 nondemented age‐matched controls. Astrocyte/oligodendrocyte ratio (AOR) was calculated, total glial counts and AOR were compared with severity of WMD, and Alzheimer encephalopathy grade was subjectively assessed. Astrocytic numbers, AOR and astrocytic reactivity proved to be significantly higher in the demented group, whereas oligodendrocytic and total glial counts were significantly lower. Furthermore, AOR proved to be positively correlated with severity of WMD, whereas no association was found with Alzheimer encephalopathy. We conclude that WMD in dementia, for example, of the type seen in AD, can easily be detected, measured and graded quantitatively, with AOR being a significant indicator of the severity of changes. This could serve as a tool for differentiating white matter pathologies in dementia and may be the basis for recognition of the mildest white matter changes with new imaging methods, and enable potential clinical intervention.

[1]  L. Wahlund,et al.  White matter hyperintensities in dementia: does it matter? , 1994, Magnetic resonance imaging.

[2]  H. Chui,et al.  Dementia due to subcortical ischemic vascular disease. , 2001, Clinical cornerstone.

[3]  K. Blennow,et al.  Symptoms, Vascular Risk Factors and Blood-Brain Barrier Function in Relation to CT White-Matter Changes in Dementia , 2000, European Neurology.

[4]  Elna-Marie Larsson,et al.  Magnetic Resonance Imaging and Histopathology in Dementia, Clinically of Frontotemporal Type , 2000, Dementia and Geriatric Cognitive Disorders.

[5]  M. Janelidze,et al.  Cognitive correlates of leukoaraiosis in the early stages of Alzheimer's disease. , 1998, Functional neurology.

[6]  O Almkvist,et al.  White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.

[7]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[8]  B. Winblad,et al.  CADASIL: hereditary disease of arteries causing brain infarcts and dementia , 1999, Neuropathology and applied neurobiology.

[9]  A Brun,et al.  White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments , 1990, Histopathology.

[10]  V. Hachinski,et al.  Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. , 1991, Archives of neurology.

[11]  E. Englund,et al.  Cerebral Amyloid Angiopathy, White Matter Lesions and Alzheimer Encephalopathy – A Histopathological Assessment , 2002, Dementia and Geriatric Cognitive Disorders.

[12]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[13]  A. Brun,et al.  Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[14]  A. Brun,et al.  Frontal lobe degeneration of non-Alzheimer type. IV. White matter changes. , 1987, Archives of gerontology and geriatrics.

[15]  S. Berg,et al.  The influence of white matter lesions on neuropsychological functioning in demented and non‐demented 85‐year‐olds , 1996, Acta neurologica Scandinavica.

[16]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[17]  T. Erkinjuntti,et al.  White matter low attenuation on CT in Alzheimer's disease. , 1989, Archives of gerontology and geriatrics (Print).

[18]  B Horwitz,et al.  White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. , 1990, Archives of neurology.

[19]  T Suenaga,et al.  Alterations in glia and axons in the brains of Binswanger's disease patients. , 1997, Stroke.

[20]  Scott T. Grafton,et al.  Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. , 1991, Archives of neurology.

[21]  A Brun,et al.  CORRELATIONS BETWEEN HISTOPATHOLOGIC WHITE MATTER CHANGES AND PROTON MR RELAXATION TIMES IN DEMENTIA , 1987, Alzheimer disease and associated disorders.

[22]  H. Arai,et al.  Distribution of amyloid deposits in the cerebral white matter of the Alzheimer’s disease brain: relationship to blood vessels , 1997, Acta Neuropathologica.

[23]  A Brun,et al.  White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. , 1988, Brain : a journal of neurology.

[24]  Derek K. Jones,et al.  Normal-appearing white matter in ischemic leukoaraiosis: A diffusion tensor MRI study , 2001, Neurology.

[25]  A. Brun,et al.  Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading , 1981, Histopathology.

[26]  T. Erkinjuntti,et al.  CT in the differential diagnosis between Alzheimer's disease and vascular dementia , 1987, Acta neurologica Scandinavica.

[27]  D. Bennett,et al.  Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease , 1992, Journal of Neurology.

[28]  D. Leys,et al.  Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. , 1990, Archives of neurology.

[29]  D. Bennett,et al.  White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. , 1994, Dementia.

[30]  A. Brun,et al.  A white‐matter disease in dementia of Alzheimer's type – clinical and neuropathological correlates , 1989 .

[31]  F. Fazekas,et al.  The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease , 1996, Journal of the Neurological Sciences.

[32]  V. Hachinski,et al.  Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.

[33]  C. Filley,et al.  CADASIL: Neuropsychological findings in three generations of an affected family , 2001, Journal of the International Neuropsychological Society.

[34]  R. Schmidt,et al.  Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. , 1992, European neurology.

[35]  Elisabet Englund,et al.  Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia , 1998, Dementia and Geriatric Cognitive Disorders.

[36]  V. Challa,et al.  Cerebrovascular Pathology in Alzheimer's Disease and Leukoaraiosis , 2000, Annals of the New York Academy of Sciences.